vs

Side-by-side financial comparison of Edwards Lifesciences (EW) and Roblox Corp (RBLX). Click either name above to swap in a different company.

Edwards Lifesciences is the larger business by last-quarter revenue ($1.6B vs $1.4B, roughly 1.2× Roblox Corp). Edwards Lifesciences runs the higher net margin — 23.1% vs -22.3%, a 45.4% gap on every dollar of revenue. On growth, Roblox Corp posted the faster year-over-year revenue change (43.2% vs 16.7%). Over the past eight quarters, Roblox Corp's revenue compounded faster (32.9% CAGR vs 9.7%).

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.

Roblox Corporation is an American video game developer based in San Mateo, California. Founded in 2004 by David Baszucki and Erik Cassel, the company is the developer of Roblox, a game platform, which was released in 2006. As of December 31, 2024, the company employs over 2,400 people.

EW vs RBLX — Head-to-Head

Bigger by revenue
EW
EW
1.2× larger
EW
$1.6B
$1.4B
RBLX
Growing faster (revenue YoY)
RBLX
RBLX
+26.5% gap
RBLX
43.2%
16.7%
EW
Higher net margin
EW
EW
45.4% more per $
EW
23.1%
-22.3%
RBLX
Faster 2-yr revenue CAGR
RBLX
RBLX
Annualised
RBLX
32.9%
9.7%
EW

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EW
EW
RBLX
RBLX
Revenue
$1.6B
$1.4B
Net Profit
$380.7M
$-316.0M
Gross Margin
78.0%
77.7%
Operating Margin
1.8%
-25.3%
Net Margin
23.1%
-22.3%
Revenue YoY
16.7%
43.2%
Net Profit YoY
6.8%
-43.9%
EPS (diluted)
$0.66
$-0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EW
EW
RBLX
RBLX
Q1 26
$1.6B
Q4 25
$1.6B
$1.4B
Q3 25
$1.6B
$1.4B
Q2 25
$1.5B
$1.1B
Q1 25
$1.4B
$1.0B
Q4 24
$1.4B
$988.2M
Q3 24
$1.4B
$919.0M
Q2 24
$1.4B
$893.5M
Net Profit
EW
EW
RBLX
RBLX
Q1 26
$380.7M
Q4 25
$91.2M
$-316.0M
Q3 25
$291.1M
$-255.6M
Q2 25
$333.2M
$-278.4M
Q1 25
$358.0M
$-215.1M
Q4 24
$385.6M
$-219.6M
Q3 24
$3.1B
$-239.3M
Q2 24
$366.3M
$-205.9M
Gross Margin
EW
EW
RBLX
RBLX
Q1 26
78.0%
Q4 25
78.1%
77.7%
Q3 25
77.8%
78.2%
Q2 25
77.5%
78.2%
Q1 25
78.7%
78.3%
Q4 24
78.9%
77.9%
Q3 24
80.6%
77.7%
Q2 24
79.9%
77.8%
Operating Margin
EW
EW
RBLX
RBLX
Q1 26
1.8%
Q4 25
9.6%
-25.3%
Q3 25
19.8%
-21.8%
Q2 25
26.8%
-29.8%
Q1 25
27.9%
-24.6%
Q4 24
22.6%
-24.7%
Q3 24
25.9%
-30.4%
Q2 24
26.8%
-26.6%
Net Margin
EW
EW
RBLX
RBLX
Q1 26
23.1%
Q4 25
5.8%
-22.3%
Q3 25
18.7%
-18.8%
Q2 25
21.7%
-25.8%
Q1 25
25.3%
-20.8%
Q4 24
27.8%
-22.2%
Q3 24
226.7%
-26.0%
Q2 24
26.7%
-23.0%
EPS (diluted)
EW
EW
RBLX
RBLX
Q1 26
$0.66
Q4 25
$0.16
$-0.44
Q3 25
$0.50
$-0.37
Q2 25
$0.56
$-0.41
Q1 25
$0.61
$-0.32
Q4 24
$0.65
$-0.32
Q3 24
$5.13
$-0.37
Q2 24
$0.61
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EW
EW
RBLX
RBLX
Cash + ST InvestmentsLiquidity on hand
$3.1B
Total DebtLower is stronger
$1.2B
Stockholders' EquityBook value
$394.5M
Total Assets
$9.6B
Debt / EquityLower = less leverage
2.98×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EW
EW
RBLX
RBLX
Q1 26
Q4 25
$4.2B
$3.1B
Q3 25
$3.8B
$2.9B
Q2 25
$4.1B
$2.6B
Q1 25
$3.9B
$2.7B
Q4 24
$4.0B
$2.4B
Q3 24
$4.4B
$2.3B
Q2 24
$2.0B
$2.4B
Total Debt
EW
EW
RBLX
RBLX
Q1 26
Q4 25
$1.2B
Q3 25
Q2 25
Q1 25
Q4 24
$1.2B
Q3 24
Q2 24
Stockholders' Equity
EW
EW
RBLX
RBLX
Q1 26
Q4 25
$10.3B
$394.5M
Q3 25
$10.2B
$407.6M
Q2 25
$10.5B
$353.2M
Q1 25
$10.1B
$310.7M
Q4 24
$10.0B
$221.4M
Q3 24
$9.5B
$189.9M
Q2 24
$7.4B
$121.5M
Total Assets
EW
EW
RBLX
RBLX
Q1 26
Q4 25
$13.7B
$9.6B
Q3 25
$13.3B
$8.6B
Q2 25
$13.5B
$7.8B
Q1 25
$13.0B
$7.5B
Q4 24
$13.1B
$7.2B
Q3 24
$13.0B
$6.7B
Q2 24
$10.1B
$6.5B
Debt / Equity
EW
EW
RBLX
RBLX
Q1 26
Q4 25
2.98×
Q3 25
Q2 25
Q1 25
Q4 24
5.48×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EW
EW
RBLX
RBLX
Operating Cash FlowLast quarter
$607.0M
Free Cash FlowOCF − Capex
$308.6M
FCF MarginFCF / Revenue
21.8%
Capex IntensityCapex / Revenue
21.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EW
EW
RBLX
RBLX
Q1 26
Q4 25
$450.9M
$607.0M
Q3 25
$573.7M
$546.2M
Q2 25
$290.2M
$199.3M
Q1 25
$280.4M
$443.9M
Q4 24
$-127.5M
$184.5M
Q3 24
$351.8M
$247.4M
Q2 24
$371.5M
$151.4M
Free Cash Flow
EW
EW
RBLX
RBLX
Q1 26
Q4 25
$353.5M
$308.6M
Q3 25
$516.2M
$443.6M
Q2 25
$240.9M
$176.7M
Q1 25
$224.4M
$426.5M
Q4 24
$-177.3M
$120.6M
Q3 24
$299.9M
$218.0M
Q2 24
$286.1M
$111.7M
FCF Margin
EW
EW
RBLX
RBLX
Q1 26
Q4 25
22.5%
21.8%
Q3 25
33.2%
32.6%
Q2 25
15.7%
16.3%
Q1 25
15.9%
41.2%
Q4 24
-12.8%
12.2%
Q3 24
22.1%
23.7%
Q2 24
20.9%
12.5%
Capex Intensity
EW
EW
RBLX
RBLX
Q1 26
Q4 25
6.2%
21.1%
Q3 25
3.7%
7.5%
Q2 25
3.2%
2.1%
Q1 25
4.0%
1.7%
Q4 24
3.6%
6.5%
Q3 24
3.8%
3.2%
Q2 24
6.2%
4.4%
Cash Conversion
EW
EW
RBLX
RBLX
Q1 26
Q4 25
4.94×
Q3 25
1.97×
Q2 25
0.87×
Q1 25
0.78×
Q4 24
-0.33×
Q3 24
0.11×
Q2 24
1.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons